000 | 01990 a2200529 4500 | ||
---|---|---|---|
005 | 20250515215804.0 | ||
264 | 0 | _c20100922 | |
008 | 201009s 0 0 eng d | ||
022 | _a1941-7705 | ||
024 | 7 |
_a10.1161/CIRCOUTCOMES.109.890707 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHo, P Michael | |
245 | 0 | 0 |
_aAdverse events after stopping clopidogrel in post-acute coronary syndrome patients: Insights from a large integrated healthcare delivery system. _h[electronic resource] |
260 |
_bCirculation. Cardiovascular quality and outcomes _cMay 2010 |
||
300 |
_a303-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAcute Coronary Syndrome _xcomplications |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aClopidogrel |
650 | 0 | 4 | _aDelivery of Health Care, Integrated |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
650 | 0 | 4 | _aPatient Discharge |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aTiclopidine _xanalogs & derivatives |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aWithholding Treatment |
700 | 1 | _aTsai, Thomas T | |
700 | 1 | _aWang, Tracy Y | |
700 | 1 | _aShetterly, Susan M | |
700 | 1 | _aClarke, Christina L | |
700 | 1 | _aGo, Alan S | |
700 | 1 | _aSedrakyan, Art | |
700 | 1 | _aRumsfeld, John S | |
700 | 1 | _aPeterson, Eric D | |
700 | 1 | _aMagid, David J | |
773 | 0 |
_tCirculation. Cardiovascular quality and outcomes _gvol. 3 _gno. 3 _gp. 303-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCOUTCOMES.109.890707 _zAvailable from publisher's website |
999 |
_c19714881 _d19714881 |